Coincidence of two rare neurologic diseases detected by panel next-generation sequencing
Abstract
Keywords
About the Authors
G. E. RudenskayaRussian Federation
A. O. Shumarina
Russian Federation
A. V. Antonets
Russian Federation
I. G. Sermyagina
Russian Federation
T. D. Krylova
Russian Federation
O. A. Shchagina
Russian Federation
References
1. Mоller RS, Dahl HA, Helbig I. The contribution of next generation sequencing to epilepsy genetics. Expert Rev Mol Diagn. 2015; 15: 1531-1538.
2. OMIM (On-line Mendelian Inheritance in Man) http://www.ncbi.nlm.nih.gov
3. Allen AS, Berkovic SF, Cossette P et al. Epi4K Consortium; Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 2013; 501: 217-221.
4. Epi4K Consortium. De Novo Mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies Am J Hum Genet. 2016; 99: 287-298.
5. Hino-Fukuyo N, Kikuchi A, Arai-Ichinoi N et al. Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome. Hum Genet. 2015; 134: 649-658.
6. Fassone E, Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet. 2012; 49: 578-590.
7. Haack TB, Haberberger B, Frisch EM et al. Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing. J Med Genet. 2012; 49: 277-283.
8. Calvo SE, Compton AG, Hershman SG et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med. 2012; 4: 118ra10.
9. Alston CL, Howard C, Olаhovа M et al. A recurrent mitochondrial p.Trp22Arg NDUFB3 variant causes a distinctive facial appearance, short stature and a mild biochemical and clinical phenotype. J Med Genet. 2016; 53(9): 634-641.
Review
For citations:
Rudenskaya G.E., Shumarina A.O., Antonets A.V., Sermyagina I.G., Krylova T.D., Shchagina O.A. Coincidence of two rare neurologic diseases detected by panel next-generation sequencing. Medical Genetics. 2017;16(11):38-41. (In Russ.)